A!maginostic
A!maginostic is an A*STAR IMCB spin-off company incorporated in Oct. 2017, focusing on providing model-based digital pathology solutions and services. They aim to optimize pathology workflows, empower pathologists and researchers with advanced analytic capabilities, and support clinical decisions and accelerate drug discovery. The company integrates methodologies from signal processing, image processing, computer vision, optimization, machine learning, pattern recognition, mathematical modeling, AI, and Deep Learning, with input from medical professionals. Their core technical team has over ten years of experience in designing robust solutions for cellular image analysis and molecule diagnosis. A!maginostic has established partnerships with clinical institutions and research organizations and aims to push quantitative and reliable cellular/molecular image analysis and diagnosis solutions from academic research to clinical decision-making.
A!maginostic
A!maginostic is an A*STAR IMCB spin-off company incorporated in Oct. 2017, focusing on providing model-based digital pathology solutions and services. They aim to optimize pathology workflows, empower pathologists and researchers with advanced analytic capabilities, and support clinical decisions and accelerate drug discovery. The company integrates methodologies from signal processing, image processing, computer vision, optimization, machine learning, pattern recognition, mathematical modeling, AI, and Deep Learning, with input from medical professionals. Their core technical team has over ten years of experience in designing robust solutions for cellular image analysis and molecule diagnosis. A!maginostic has established partnerships with clinical institutions and research organizations and aims to push quantitative and reliable cellular/molecular image analysis and diagnosis solutions from academic research to clinical decision-making.